Assani Ganiou, Zhou Yunfeng
Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Oncol Lett. 2019 Jan;17(1):23-30. doi: 10.3892/ol.2018.9636. Epub 2018 Oct 29.
Cancer is one of the leading causes of cancer-associated mortality worldwide. Several strategies of treatment, including radiotherapy, have been developed and used to treat this disease. However, post-treatment metastasis and resistance to treatment are two major causes for the limited effectiveness of radiotherapy in cancer patients. Epithelial-mesenchymal transition (EMT) is regulated by SNAIL family transcription factors, including Snail1 and Snail2 (Slug), and serves important roles in progression and cancer resistance to treatment. Snail1 and Slug also have been shown to be implicated in cancer treatment resistance. For resolving the resistance to treatment problems, combining the modulation of gene expression with radiotherapy is a novel strategy to treat patients with cancer. The present review focuses on the effect of Snail1 and Slug on cancer radiosensitivity by targeting cell apoptosis, the cell cycle and cell migration/invasion.
癌症是全球癌症相关死亡的主要原因之一。已经开发并使用了包括放射疗法在内的几种治疗策略来治疗这种疾病。然而,治疗后转移和治疗抗性是放射疗法在癌症患者中疗效有限的两个主要原因。上皮-间质转化(EMT)受SNAIL家族转录因子调控,包括Snail1和Snail2(Slug),并在癌症进展和抗治疗中发挥重要作用。Snail1和Slug也已被证明与癌症治疗抗性有关。为了解决治疗抗性问题,将基因表达调控与放射疗法相结合是治疗癌症患者的一种新策略。本综述重点关注Snail1和Slug通过靶向细胞凋亡、细胞周期和细胞迁移/侵袭对癌症放射敏感性的影响。